Welcome to our dedicated page for Adient SEC filings (Ticker: ADNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Understanding Adient's financial position requires navigating SEC filings that detail the company's performance across its global automotive seating operations. The company's 10-K annual reports break down revenue by geographic region and customer concentration, revealing how dependent the business is on specific automakers and production regions.
Adient's quarterly 10-Q filings track how vehicle production fluctuations affect the seating supplier's performance. These reports provide segment-level detail on operations in the Americas, Europe, and Asia, showing which regions contribute most to profitability and where challenges emerge. Our AI summaries highlight these regional breakdowns without requiring you to parse through extensive financial tables.
Form 4 insider transaction filings track when Adient executives and directors buy or sell company shares. These transactions can provide signals about management confidence, particularly around earnings announcements and major business developments. Access executive stock transactions alongside filing context.
The company's 8-K filings announce material events including quarterly earnings releases, supply agreement developments, and corporate actions. Proxy statements (DEF 14A) detail executive compensation structures and how leadership incentives align with shareholder interests—important information for understanding how the company's tier-one automotive supplier business model translates into management rewards.
For investors analyzing the automotive supply chain, Adient's filings provide insight into the economics of seating manufacturing, including raw material exposure, labor cost structures, and the long-term nature of OEM supply relationships.
FMR LLCAdient plc (ADNT). As of the event date 09/30/2025, FMR LLC reported beneficial ownership of 4,985,555.65 shares of common stock, representing 6.1% of the class.
FMR LLC reported sole voting power over 4,955,055.00 shares and sole dispositive power over 4,985,555.65 shares, with no shared voting or dispositive power. Abigail P. Johnson is also a reporting person, with sole dispositive power over 4,985,555.65 shares and no voting power.
The certification states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.
Adient plc furnished a Form 8-K announcing its fourth-quarter and fiscal year results for the period ended September 30, 2025. The company made the announcement via a news release dated November 5, 2025, which is included as Exhibit 99.1.
The information in the news release is furnished and not deemed filed under the Securities Exchange Act of 1934, and is incorporated by reference only if expressly stated in a future filing. Adient’s ordinary shares trade on the NYSE under the symbol ADNT.
Adient plc amended its Amended and Restated Revolving Credit Agreement. The change extends the maturity date to a date that is five years from October 17, 2025 and sets aggregate lender commitments at $1,000,000,000. The agreement continues to be guaranteed on a secured basis by the company and certain material wholly owned restricted subsidiaries.
The facility remains administered by JPMorgan Chase Bank, N.A. as administrative and collateral agent, with Adient US LLC as lead borrower. This amendment refreshes the tenor of the revolving credit line while aligning the committed size at $1.0 billion, preserving secured guarantees across key subsidiaries.
Dimensional Fund Advisors LP reported beneficial ownership of 4,215,764 shares of Adient PLC common stock, representing
Hotchkis and Wiley Capital Management, LLC filed an amendment to Schedule 13G reporting beneficial ownership of 3,251,560 ordinary shares of Adient plc, equal to 3.87% of the class. The filing states HWCM has sole dispositive power over 3,251,560 shares and sole voting power over 2,908,460 shares, with no shared voting or dispositive power reported. HWCM is identified as a Delaware investment adviser with a principal business address in Los Angeles. The filing includes a certification that the shares are held in the ordinary course of business and not for the purpose of changing control. The report is signed by Tina H. Kodama, Chief Compliance Officer, dated 08/13/2025.
Adient plc disclosed that representatives will hold meetings with certain investors in August 2025 and furnished the investor presentation used at those meetings as Exhibit 99.1 to this Form 8-K. The company states the presentation is furnished and therefore not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings except where expressly stated. The filing identifies Adient ordinary shares (par value $0.001) trading as ADNT on the New York Stock Exchange and lists the Inline XBRL cover page as Exhibit 104.
Jerome J. Dorlack, who is listed as President and CEO and a director of Adient plc (ADNT), reported a sale of ordinary shares on 08/07/2025. The filing discloses a disposition of 12,000 ordinary shares at a weighted average price of $22.77 per share, with sale prices ranging from $22.76 to $22.90. Following the reported transaction, the reporting person beneficially owned 441,025 shares on a direct basis. No derivative securities were reported on this form. The Form 4 was signed by an attorney-in-fact, Brett L. Eilander, on 08/08/2025.
Adient plc submitted a Form 144 disclosing a proposed sale of 12,000 common shares acquired as restricted stock units on 11/18/2022. The shares are to be sold through Oppenheimer & Co. Inc. on the NYSE with an approximate aggregate market value of $271,119.00 and total shares outstanding listed as 81,245,928. The filing shows no securities sold by the reporting person in the past three months. The notice includes the signer’s representation that they are not aware of any undisclosed material adverse information about the issuer.
Form 8-K (Item 2.02): On 6 Aug 2025 Adient plc (ADNT) disclosed that it has furnished, rather than filed, a news release detailing results for the fiscal third quarter ended 30 Jun 2025. The release is provided as Exhibit 99.1 and is expressly incorporated into this report only by reference. No revenue, EPS, margin or guidance figures appear in the filing itself; investors must review Exhibit 99.1 to obtain the underlying financial data. The company also supplied the customary Exhibit 104 cover-page XBRL file.
FAQ
What is the current stock price of Adient (ADNT)?
What is the market cap of Adient (ADNT)?
